chr19-13207394-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001127222.2(CACNA1A):​c.7440C>G​(p.His2480Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00215 in 1,538,980 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. H2480H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0022 ( 10 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.349

Publications

4 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012342066).
BP6
Variant 19-13207394-G-C is Benign according to our data. Variant chr19-13207394-G-C is described in ClinVar as Benign. ClinVar VariationId is 994534.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00164 (248/151620) while in subpopulation NFE AF = 0.00314 (213/67752). AF 95% confidence interval is 0.0028. There are 0 homozygotes in GnomAd4. There are 113 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 248 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127222.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
NM_001127222.2
MANE Select
c.7440C>Gp.His2480Gln
missense
Exon 47 of 47NP_001120694.1O00555-8
CACNA1A
NM_001127221.2
MANE Plus Clinical
c.*652C>G
3_prime_UTR
Exon 47 of 47NP_001120693.1O00555-3
CACNA1A
NM_023035.3
c.7458C>Gp.His2486Gln
missense
Exon 48 of 48NP_075461.2A0A087WW63

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
ENST00000360228.11
TSL:1 MANE Select
c.7440C>Gp.His2480Gln
missense
Exon 47 of 47ENSP00000353362.5O00555-8
CACNA1A
ENST00000638029.1
TSL:5
c.7458C>Gp.His2486Gln
missense
Exon 48 of 48ENSP00000489829.1A0A087WW63
CACNA1A
ENST00000573710.7
TSL:5
c.7446C>Gp.His2482Gln
missense
Exon 47 of 47ENSP00000460092.3A0A1C7CYY9

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
248
AN:
151512
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000339
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000460
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.000856
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00314
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.00150
AC:
213
AN:
141688
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.000321
Gnomad AMR exome
AF:
0.000356
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000913
Gnomad NFE exome
AF:
0.00305
Gnomad OTH exome
AF:
0.00189
GnomAD4 exome
AF:
0.00221
AC:
3061
AN:
1387360
Hom.:
10
Cov.:
30
AF XY:
0.00218
AC XY:
1500
AN XY:
686664
show subpopulations
African (AFR)
AF:
0.000257
AC:
8
AN:
31100
American (AMR)
AF:
0.000273
AC:
10
AN:
36672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24854
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35776
South Asian (SAS)
AF:
0.000760
AC:
61
AN:
80250
European-Finnish (FIN)
AF:
0.00119
AC:
41
AN:
34586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5666
European-Non Finnish (NFE)
AF:
0.00258
AC:
2791
AN:
1080784
Other (OTH)
AF:
0.00260
AC:
150
AN:
57672
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
173
345
518
690
863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
248
AN:
151620
Hom.:
0
Cov.:
31
AF XY:
0.00152
AC XY:
113
AN XY:
74148
show subpopulations
African (AFR)
AF:
0.000338
AC:
14
AN:
41424
American (AMR)
AF:
0.000459
AC:
7
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5096
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4816
European-Finnish (FIN)
AF:
0.000856
AC:
9
AN:
10514
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00314
AC:
213
AN:
67752
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00134
Hom.:
0
Bravo
AF:
0.00133
ExAC
AF:
0.00108
AC:
113

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
15
DANN
Benign
0.87
DEOGEN2
Benign
0.0074
T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.65
T
M_CAP
Pathogenic
0.97
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.34
T
PhyloP100
-0.35
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.23
Sift
Benign
0.57
T
Sift4G
Benign
0.45
T
Vest4
0.093
MutPred
0.17
Loss of solvent accessibility (P = 0.0468)
MVP
0.69
MPC
0.28
ClinPred
0.0013
T
GERP RS
0.82
Varity_R
0.058
gMVP
0.26
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs539546830; hg19: chr19-13318208; API